[1]
T. McLaughlin, D. Rakestraw, H. Okut, and E. Ablah, “Adverse Events Reported Following RSV Prefusion F Protein Vaccines Administration Among Approved Populations: A Cross-Sectional Study”, kjm, vol. 18, no. 6, pp. 129–133, Dec. 2025, doi: 10.17161/kjm.vol18.23980.